Table of Content
- Vol.32, No.1, 2024
- Vol.32, No.2, 2024
- Vol.32, No.3, 2024
- Vol.32, No.4, 2024
- Vol.32, No.5, 2024
- Vol.32, No.6, 2024
- Vol.32, No.7, 2024
- Vol.32, No.8, 2024
- Vol.31, No.1, 2023
- Vol.31, No.2, 2023
- Vol.31, No.3, 2023
- Vol.31, No.4, 2023
- Vol.31, No.5, 2023
- Vol.31, No.6, 2023
- Vol.30, No.1, 2022
- Vol.30, No.2, 2022
- Vol.30, No.3, 2022
- Vol.30, No.4, 2022
- Vol.30, No.5, 2022
- Vol.30, No.6, 2022
- Vol.29, No.1, 2021
- Vol.29, No.2, 2021
- Vol.29, No.3, 2021
- Vol.29, No.4, 2021
- Vol.29, No.5, 2021
- Vol.29, No.6, 2021
- Vol.28, No.1, 2020
- Vol.28, No.2, 2020
- Vol.28, No.3, 2020
- Vol.28, No.4, 2020
- Vol.28, No.5, 2020
- Vol.28, No.6, 2020
- Vol.28, No.7-8, 2020
- Vol.28, No.9, 2020
- Vol.27, No.1, 2019
- Vol.27, No.2, 2019
- Vol.27, No.3, 2019
- Vol.27, No.4, 2019
- Vol.27, No.5, 2019
- Vol.27, No.6, 2019
- Vol.27, No.7, 2019
- Vol.27, No.8, 2019
- Vol.27, No.9, 2019
- Vol.26, No.1, 2018
- Vol.26, No.2, 2018
- Vol.26, No.3, 2018
- Vol.26, No.4, 2018
- Vol.26, No.5, 2018
- Vol.26, No.6, 2018
- Vol.26, No.7, 2018
- Vol.26, No.8, 2018
- Vol.26, No.9, 2018
- Vol.25, No.1, 2017
- Vol.25, No.2, 2017
- Vol.25, No.3, 2017
- Vol.25, No.4, 2017
- Vol.25, No.5, 2017
- Vol.25, No.6, 2017
- Vol.25, No.7, 2017
- Vol.25, No.8, 2017
- Vol.25, No.9, 2017
- Vol.24, No.1, 2016
- Vol.24, No.2, 2016
- Vol.24, No.3, 2016
- Vol.24, No.4, 2016
- Vol.24, No.5, 2016
- Vol.24, No.6, 2016
Editors-in-Chief
-
Edward Chu
Albert Einstein College of Medicine, USA
Interests: cancer pharmacology and drug development
-
Enrico Mini
University of Florence Florence, ITALY
Interests: the mechanisms of tumor drug resistance, in particular to antimetabolites and metal-based drugs, cancer pharmacogenomics and pharmacogenetics, and controlled clinical trials in gastrointestinal cancers
-
Hailin Tang
Sun Yat-sen University Cancer Center, CHINA
Interests: The molecular mechanism of tumorigenesis and metastasis
Editorial Board Members
-
Sirin A. Adham
Department of Biology, College of Science, Sultan Qaboos University, Muscat, OMAN
Interests: breast cancer, integrin beta 3, chemoresistance, adriamycin, cyclophosphamide
-
Aamir Ahmad
University of Alabama at Birmingham, USA
Interests: cancer metastasis, drug resistance, miRNA and cancer health disparity
-
Mamoun Ahram
The University of Jordan, JORDAN
Interests: cancer biology, molecular and cell biology, biobanking, breast cancer, androgen
-
Dante Amelio
Proton Therapy Center, Azienda Provinciale per i Servizi Sanitari (APSS), ITALY
Interests: astrocytoma, bone tumor, brain tumor, chordoma, craniopharyngioma, glioblastoma, meningioma, pituitary tumor, schwannoma
-
Roberto Bei
Facoltà di Medicina e Chirurgia Università degli Studi di Roma Tor Vergata Rome, ITALY
Interests: Oncology: Analysis of immune response to tumor associated antigens (ErbB receptors, AFP, CEA, PSA) in cancer patients and cancer immunotherapy. Analysis of the expression of tumor antigens in tumors and normal tissues; Virology: Production and characterization of monoclonal antibodies to viral proteins; Nutrition: Effect of natural compounds on cancer cell growth.
-
Luca Bertolaccini
European Institute of Oncology IRCCS, ITALY
Interests: lung cancer surgery, minimally invasive thoracic surgery, thoracic oncology, biostatistics
-
Guido Bocci
University of Pisa, ITALY
Interests: Cancer Biology; Clinical Studies; Pharmacodynamics; Clinical Pharmacokinetics; Pharmacokinetics; Genetics Oncology; Tumors; Cancer Research
-
Giuseppe Broggi
Department “G.F. Ingrassia”, Anatomic Pathology, University of Catania, ITALY
Interests: Molecular Biology, Cancer Research, Neuropathology and Histopathology
-
George Gong CHEN
The Chinese University of Hong Kong, HONG KONG
Interests: head and neck cancers, especially thyroid cancer and laryngeal cancer
-
William CHO
Queen Elizabeth Hospital, HONG KONG
Interests: molecular biology, proteomics, genomics, immunology, bioinformatics, next-generation sequencing
-
Maria Caffo
University of Messina, ITALY
Interests: glioblastoma multiforme (GBM), astrocytoma, medulloblastoma, neuroradiology, magnetic resonance, glioma, molecular oncology, meningioma,neurosurgery
-
Jianyuan Chai
Inner Mongolia University of Science and Technology, CHINA
Interests: molecular and cellular biology of wound healing, angiogenesis, apoptosis, cancer development, esophageal cancer, gastrointestinal injury and malignancy
-
Nipon Chattipakorn
Cardiac Electrophysiology Research and Training Center (CERT), Thailand; Faculty of Medicine, Chiang Mai University, THAILAND
Interests: Cardio-oncology, chemotherapy-induced cardiotoxicity, mitochondria, programmed cell death, molecular cardiology
-
Xiaofang Che
The First Hospital of China Medical University, CHINA
Interests: tumor microenvironment, hypoxia, immunology, cancer, proliferation, drug resistance, metastasis, exosome, non-cording RNA, m6A methylation, post-translational modification, biomarker
-
Tianhui Chen
Zhejiang Cancer Hospital, CHINA
Interests: clinical epidemiology, molecular epidemiology, genetic epidemiology of familial cancer (colorectal cancer, breast cancer, ovarian cancer, pancreatic cancer)
-
Maoquan Chu
Tongji University, CHINA
Interests: advanced nanostructures for in vivo target drug delivery, advanced nanostructures and strategy for in vivo cancer target imaging and therapy
-
Ri Cui
School of Pharmaceutical Sciences Wenzhou Medical University, CHINA
Interests: Bioinformatics, Cancer Research, Cell Biology, non-coding RNAs, cancer pathogenesis
-
Valentina De Falco
Consiglio Nazionale delle Ricerche, ITALY
Interests: Molecular Oncology, Preclinical Investigation, Targeted Therapies, Kinase Inhibitors, Personalized Medicine
-
Vittorio Gebbia
University of Enna Kore, ITALY
Interests: medial oncology, hematology, lung cancer, chemotherapy
-
David A. Gewirtz
Virginia Commonwealth University, USA
Interests: autophagy, cell biology, programmed cell death, apoptosis and senescence
-
Bahil Ghanim
Karl Landsteiner University of Health Sciences, AUSTRIA
Interests: biomarkers, thoracic surgery, lung cancer, mesothelioma, minimal invasive surgery and solitary fibrous tumor of the lung
-
Pia Giovannelli
University of Campania “L. Vanvitelli”, ITALY
Interests: cancer biology, molecular biology, cancer cells, epigenetics, gene expression
-
Nocentini Giuseppe
University of Perugia, ITALY
Interests: pharmacology, immunotoxicology and pharmacoimmunology
-
Manuel Graeber
The University of Sydney, AUSTRALIA
Interests: brain tumours, glioblastoma, microglia, brain macrophages, tumour microenvironment, neurogenetics
-
Zongsheng Guo
Roswell Park Comprehensive Cancer Center, UNITED STATES
Interests: Cancer Immunotherapy, Oncolytic Viruses, Epigenetic Therapy, and Cancer Biology
-
Sanjay Gupta
Case Western Reserve University, USA
Interests: cancer biomarkers, cancer therapeutics and drug repurposing and cancer stem cells research
-
Jing He
Guangzhou Women and Children's Medical Center, CHINA
Interests: cancer genetics, cancer epidemiology, molecular epidemiology, cancer therapy, signal transduction, pediatric oncology, evidence-based medicine (meta-analysis), molecular biology
-
Mehdi Hedayati
Shahid Beheshti University of Medical Sciences, Research Institute for Endocrine Science, Cellular and Molecular Endocrine Research Center, IRAN
Interests: biochemistry and genetic aspects of thyroid cancer, biostatistics, endocrine oncology
-
Ryouichi Horie
Kitasato University, JAPAN
Interests: molecular hematology, medical sciences
-
Ciro Isidoro
Università del Piemonte Orientale, ITALY
Interests: cancer biology, autophagy, cell death, cell biology, cancer research, apoptosis, cell proliferation
-
Gyeong-Hoon Kang
Department of Pathology, Seoul National University College of Medicine, Seoul, Korea; Laboratory of Epigenetics, Seoul National University Cancer Research Institute, Seoul, KOREA
Interests: Lower gastrointestinal tract pathology, DNA methylation, Epigenetics, Gastrointestinal cancer
-
Naoki Katase
Department of Oral Pathology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, JAPAN
Interests: Head and neck squamous cell carcinoma (HNSCC); oral cancer; gene therapy
-
Snježana Kaštelan
School of Medicine, University of Zagreb, CROATIA
Interests: etiopathogenesis of diabetic retinopathy, glaucoma, and ocular oncology
-
Shirabe Ken
Graduate School of Medical Sciences Fukuoka, JAPAN
Interests: Hepato-pancreato-biliary Surgery, Liver Transplantation Surgery
-
Cheorl-Ho Kim
Sungkyunkwan University, KOREA
Interests: innate immunity; microbe-host interasction; angiogensis; differentiation; invasion; ethnopharmcology; molecular and cellular glycobiology; cancer research
-
I-Ta Lee
School of Dentistry, Taipei Medical University, Taipei, Taiwan
Interests: Oral Pathology; Oral Medicine; Inflammatory Biomarkers; Cell Signaling; Inflammatory diseases; Cancers; Anticancer effects and mechanisms of Chinese herbal medicine
-
Chien-Feng Li
Chi Mei Medical Center, TAIWAN
Interests: the effect of genetic, epigenetic, expression, and metabolic alternations on cancer progression and metastasis
-
Yingying Lin
Shanghai Jiaotong University, CHINA
Interests: tumor microenvironment, protease, glioma
-
Tao Liu
Lowy Cancer Research Centre, AUSTRALIA
Interests: oncology and carcinogenesis, cancer cell biology, cancer genetics, cancer therapy
-
Jinhui Liu
The First Affiliated Hospital of Nanjing Medical University, CHINA
Interests: biomarker, prognostic model, non-coding RNA, machine learning, bioinformatics, immunology
-
Ying Liu
Qingdao University, CHINA
Interests: basic and applied research on nuclear receptor signal transduction, protein post-translational modification, identification of tumor biomarkers, and bioinformatics
-
Cesar Lopez-Camarillo
Universidad Autónoma de la Ciudad de México Mexico, MEXICO
Interests: microRNAs, lncRNAs and proteins deregulated in cancer using diverse omics approaches (genomics, proteomics, expression profiling, etc).
-
Wenxue Ma
University of California, USA
Interests: cancer stem cell (CSC), cancer immunotherapy, antigen presentation, tumor neoantigens, Cytotoxic T-Lymphocytes (CTLs), tumor-infiltrating lymphocytes (TILs), dug delivery with nanotechnology (Nanomedicine), targeted cancer therapy, circulating tumor cell (CTC), biomarkers
-
Muzafar Ahmad Macha
Watson-Crick Center for Molecular Medicine, Islamic University of Science and Technology (IUST), Awantipora, Kashmir, INDIA
Interests: Genetic/Epigenetic modification in cancer, Signal transduction mechanisms, Novel therapeutics for the treatment of Head and Neck Squamous cell carcinoma (HNSCC), Esophageal and Pancreatic Cancer, Development of Genetically Engineered Mouse models of HNSCC, Artificial Intelligence and Cancer
-
Chun Mao
School of Chemistry and Materials Science, Nanjing Normal University, Nanjing, CHINA
Interests: Nanobiotechnology; Nanomaterials; Bionanotechnology; Tumor Therapy
-
Sebastiano Mercadante
La Maddalena Cancer Center, ITALY
Interests: cancer pain, palliative medicine, anesthesiology
-
Constantinos Mikelis
University of Patras, GREECE
Interests: investigating the role of the small GTPase RhoA on developmental and tumor-induced angiogenesis, lymphangiogenesis, on the role of endothelial RhoA on cancer cell trans-endothelial migration, signaling circuits, genetic alterations taking place in the endothelium upon incorporation of cancer-derived exosomes, as part of the pre-metastatic niche
-
Hiroshi Miyamoto
Director of Genitourinary Pathology at University of Rochester Medical Center, Professor of Pathology & Laboratory Medicine and Urology, University of Rochester School of Medicine and Dentistry, Rochester, USA
Interests: Bladder and prostate cancers; molecular biology of steroid hormone receptors in genitourinary tumors; the role of androgen receptor signaling in promoting the development and progression of bladder cancer, as well as resistance to non-surgical therapy
-
Giovanni Monteleone
University of Rome Tor Vergata, ITALY
Interests: gastroenterology, cancer immunity and immunotherapy, liver and clinical research
-
Yuseok Moon
Pusan National University, KOREA
Interests: Microbiology, Cell Biology, Molecular Biology, Toxicology, Immunology
-
Yasser Fakhri Mustafa
Department of Pharmaceutical Chemistry, University of Mosul, Mosul, Iraq
Interests: drug design, pharmaceutical chemistry, cancer therapy
-
Jiri Neuzil
Griffith University, Brisbane, AUSTRALIA
Interests: Cancer Research, Molecular Biology, Cell Biology
-
Kiyoshi Ohtani
Department of Biomedical Sciences, School of Biological and Environmental Sciences, Kwansei Gakuin University, 1 Gakuen Uegahara, Sanda, Hyogo 669-1330, JAPAN
Interests: Cell Growth Control, Cancer Research
-
Hiroyuki Osada
RIKEN Center for Sustainable Resource Science (CSRS), JAPAN
Interests: chemical biology research
-
Chunlin Ou
Xiangya Hospital, Central South University, CHINA
Interests: the regulatory mechanism of non-coding RNAs in cancers, clinical application of mRNA vaccine in cancers.
-
Wen-Bin Ou
Zhejiang Sci-Tech University, CHINA
Interests: functional mechanisms of receptor tyrosine kinases, tumor suppressors, and oncogenes in lung cancer, mesothelioma, sarcomas, and target drug resistant mechanisms
-
Mohammad Oves
King Abdulaziz University, SAUDI ARABIA
Interests: multidrug resistance, antimicrobial agents and
nanomaterials bio-fabrication, biofilm, chromium reduction and phosphate solubilization microbe
-
Petar Ozretić
Laboratory for Hereditary Cancer, Ruđer Bošković Institute (RBI), CROATIA
Interests: cancer genetics, epigenetics, bioinformatics, biostatistics and molecular oncology
-
Pierlorenzo Pallante
IEOS, Consiglio Nazionale delle Ricerche (CNR), ITALY
Interests: non-coding RNA, cancer biology, biomarkers, cell biology, cancer therapy, prognosis, pharmacology, cancer chemotherapy, translational research in the field of lung and colorectal oncology
-
Roberto Passera
University of Torino, AOU Città della Salute e della Scienza (Molinette Hospital), ITALY
Interests: cancer clinical epidemiology and biostatistics, systematic reviews and meta-analyses in surgical oncology, chemo- and immunochemo- regimens in onco-hematology, new biomarkers for prostate cancer, pharmacokinetic and pharmacodynamic trials in oncology
-
Godefridus (Frits) J. Peters
Department Medical Oncology, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Department of Biochemistry, Medical University of Gdansk, POLAND
Interests: translation of preclinical pharmacology of anticancer agents to the clinic, regulation of transport, cellular drug distribution, metabolism of anticancer drugs, DNA repair, apoptosis and protein processing
-
Abdur Rauf
Department of Chemistry, University of Swabi, Swabi, PAKISTAN
Interests: Medicinal Chemistry; Pharmacology; Nanotechnology; Organic Chemistry; Metabolites; Pharmaceutical Chemistry; Anticancer
-
Leonardo Oliveira Reis
Pontifical Catholic University of Campinas, BRAZIL
Interests: prostate cancer; urologic surgical; bladder cancer; cancer diagnostics; urologic oncology; cryosurgery; translational research; evidence based medicine; hydronephrosis
-
Hasan Mahmud Reza
North South University, BANGLADESH
Interests: pharmaceutical dosage form development, pharmacological studies with natural products and available molecules using animal disease models, molecular biology and biochemistry, cell culture
-
Belgin SEVER
Anadolu Üniversitesi, TURKEY
Interests: targeted anticancer drug development; medicinal chemistry; computational chemistry; QSAR; molecular modelling; molecular simulations; virtual screening; in silico ADME analysis; drug design and development
-
Jan H.M. Schellens
Modra Pharmaceuticals B.V., Amsterdam, North Holland, NETHERLANDS
Interests: Medical oncology, Translational and clinical oncology research, Clinical pharmacology, Pharmacology, General internal medicine, Regulatory strategies, Health Technology Assessment, Project management, Innovation management
-
Consolato Sergi
University of Ottawa, CANADA
Interests: biology and pathology of the cardiovascular, gastrointestinal System and gut, bile microbiome, bone cell biology, pediatric pathology with nanotech applications for oncology
-
Zhendong Shi
Tianjin Medical University Cancer Institute and Hospital,CHINA
Interests: Clinical Immunology, Oncology, Nanomedicine, Breast cancer
-
Alexander Shtil
Blokhin Cancer Center, Moscow, RUSSIA
Interests: mechanisms of tumor cell death, drug resistance, antitumor drug design
-
Yang Shun-Fa
Chung Shan Medical University, Taichung, TAIWAN
Interests: pharmacology, oral cancer metastasis, cancer biology, genetic polymorphism and environment risk factors in oral cancer
-
Johnson Stanslas
Pharmacotherapeutics Unit, Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, MALAYSIA
Interests: Clinical Pharmacology, Cancer Research, Neuroscience, Oncology, Pharmacy
-
Stefania Nobili
University of Florence, ITALY
Interests: pharmacology, applied pharmacology
-
Yong Teng
Emory University School of Medicine, USA
Interests: tumor microenvironment, tumor metabolism, and metastasis with an emphasis on molecular determinants
-
Giovanni Tossetta
Dept Expt & Clin Med, Università Politecnica delle Marche, Ancona, ITALY
Interests: Endometriosis, Endometrial cancers, Ovarian Cancer, Immunofluorescence Staining, Colon Cancer, Signalling, Western Blot, Cytokines, Immunohistochemistry, ELISA, Cell Culture, Real-Time PCR
-
Chin-Hsiao Tseng
National Taiwan University Hospital, TAIWAN
Interests: diabetes, arsenic-related health hazards, cancer issues related to diabetes and antidiabetic drugs
-
Jinhua Wang
National Center for Pharmaceutical Screening, Institute of Materia Medica, CHINA
Interests: the mechanism and drug targets of cancers
-
Jaw-Yuan Wang
Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Chong-Ho Memorial Hospital, TAIWAN
Interests: Surgical and Molecular oncology, Colorectal cancer, Gastrointestinal malignancy and disease, Nutrition therapy, Robotic surgery, Microbiota
-
Paul Workman
The Institute of Cancer Research, London, UK
Interests: Cancer biology, Drug development, Drug discovery, Pre-clinical research, Personalised molecular medicine, Cancer genome
-
Guoxiong Xu
Research Center for Clinical Medicine, Jinshan Hospital, Fudan University, CHINA
Interests: Oncology, Physiology, Cell Biology, Molecular Biology, Apoptosis, Cell Signaling, Cancer Biology, Cell Proliferation, Cancer Biomarkers
-
Young Yang
Sookmyung Women's University Seoul, SOUTH KOREA
Interests: Tumor EMT&MET; Mesenchymal Stem cells and Immune regulation; Bone Homeostatsis; Metabolic rewiring
-
Hooman Yarmohammadi
Memorial Sloan-Kettering Cancer Center, USA
Interests: diagnostic radiology; diagnosis; pancreatic cancer; interventional radiology; endovascular procedures; tumors; lung; cancer biology; animal studies
-
Zhiling Yu
Hong Kong Baptist University Hong Kong, HONG KONG
Interests: Melanoma; Atopic dermatitis; Cancer; Skin care; Pharmacology; Inflammation
-
Xu Dong Zhang
University of Newcastle, AUSTRALIA
Interests: melanoma, pancreatic, colorectal & rare cancers
Early Career Editorial Board Member
-
Jiyoon Bu
INHA University, KOREA
Interests: drug delivery, nano engineering, liquid biopsy, immunotherapy
-
Meran Keshawa Ediriweera
University of Colombo, SRI LANKA
Interests: biochemistry, cancer, cancer epigenetics, pharmacognosy, ethnopharmacology
-
Abu Hazafa
University of Salerno, ITALY
Interests: CAR-T cells, tumor immunotherapy, cancer biology, natural product drug discovery
-
Zhengwei Huang
Pharmaceutics College of Pharmacy, Jinan University, Guangzhou, CHINA
Interests: nanomedicine, drug delivery, lung cancer therapy, ferroptosis, protein corona, biological fate, bibliometrics
-
Chen Li
Free University of Berlin, GERMANY
Interests: cancer metabolism; cancer immunotherapy; adipose tissue; diabetes non-alcoholic fatty liver disease
-
Fernando Mendes
Instituto Politécnico de Coimbra, PORTUGAL
Interests: lung cancer, lymphoma, blood bank, immunhematology, cancer treatement, radiotherapy, immune system, forsman blood group
-
Jialin Meng
The First Affiliated Hospital of Anhui Medical University, CHINA
Interests: clinical and basic research on prostate diseases, chronic prostatitis and prostate cancer
-
Jafar Rezaie
Solid Tumor Research Center, Urmia university of Medical Sciences, Urmia, IRAN
Interests: Extracellular Vesicles(EVs) biology; Exosome signaling pathway; Diagnosis and treatment of cancer; Developmental biology; Immunology
-
Mohsen Sheykhhasan
Cellular and Molecular Research Center, Qom University of Medical Sciences, Qom, IRAN
Interests: Hematology; Microbiology Cell; Biology; Biotechnology; Orthopedic Surgery; T-cell immunotherapy; Cell biology; Targeted cancer therapy; Biomarkers; Exosomes; Viral infection; Pathophysiology of peripheral vascular and neurological diseases; Crosstalk between long non-coding RNAs and gene signaling pathways
-
Le Su
Jacksonville State University, USA
Interests: epigenetics, childhood cancer (molecular and cellular basis of childhood sarcomas), targeted therapy
-
Yapeng Su
Program in Immunology & Herbold Computational Biology Program, Fred Hutchinson Cancer Center, UNITED STATES
Interests: cancer metabolism; cell biology; T cell therapy; systems biology; immunology; cancer
-
Yaying Sun
Huashan Hospital, CHINA
Interests: multi-organic crosstalk in terms of musculoskeletal and immune system, development of novel nanomedicine delivery system, prognostic factors and predictive model establishment of different cancers
-
Ziheng Wang
Nantong University, CHINA
Interests: bioinformatics analysis; clinical problems with machine learning; oncology using single-cell omics strategies; basic and clinical research studies; molecular pathology; etiology and pathogenesis; biomarkers; genomics; transcriptome; proteomics; metabonomics; prognosis
-
Hao Zhang
Chongqing Medical University, CHINA
Interests: tumor microenvironment; cancer immunotherapy; small molecule drug; molecular mechanism; bioinformatics; target therapy; signal transduction
-
Zhongbao Zhou
Urology Surgery, Beijing Tian Tan Hospital, Capital Medical University, CHINA
Interests: Renal Cell Carcinoma; Bladder Cancer; Prostatic Cancer
-
Yutian Zou
Sun Yat-sen University Cancer Center, CHINA
Interests: Breast cancer; Immunotherapy; Tumor microenvironment; Anti-HER2 therapy; Drug resistance; Single-cell sequencing; CRISPR; CircRNA; Cell death; Ferroptosis; Organoid; Bioinformatics
Editorial Advisory Board
-
L. J. Appleman
University of Pittsburgh, USA
Interests: tumor immunology, clinical trial of an autologous dendritic cell vaccine, cancer immunotherapy
-
N. Bahary
University of Pittsburgh, USA
Interests: oncologists diagnose, cancer surgeons, or surgical oncologists, remove tumors, while medical oncologists treat cancers with chemotherapy, gastrointestinal cancer
-
M. S. Copur
University of Nebraska, USA
Interests: medical oncology, hematology
-
S. Gantsev
Bashkirian State Medical University, RUSSIAN
Interests: pharmacology
-
Y. Horiguchi
Tokyo Medical University, JAPAN
Interests: biomaterials and bioengineering
-
M. Imoto
Keio University, JAPAN
Interests: nanotechnology, materials, chemical biology
-
H. Kakeya
Kyoto University, JAPAN
Interests: chemical biology
-
M. Kawatani
RIKEN, JAPAN
Interests: interdisciplinary science & engineering, biological sciences
-
Y. Li
Sorrento Therapeutics, USA
Interests: tumor immunology, molecular biology, medical genetics and clinical medicine
-
O. Ohno
Kogakuin University, JAPAN
Interests: immunology
-
M. Oya
Keio University, JAPAN
Interests: urology
-
A. Di Paolo
University of Pisa, ITALY
Interests: pharmacology, clinical pharmacokinetics and PK/PD of antineoplastic and antiinfective drugs
-
J. Robert
Université de Bordeaux, FRANCE
Interests: pharmacocinétique, métabolisme et résistance, pharmacologie cellulaire et moléculaire, pharmacogénétique
-
J. C. Schmitz
University of Pittsburgh, USA
Interests: pharmacodynamic, the mechanism(s) of action of quassinoids on colorectal cancer cells and tumors
-
K. Sidthipong
Mahidol University, THAILAND
Interests: biology, chemistry, bioorganic & medicinal chemistry letters
-
S. Simizu
Keio University, JAPAN
Interests: cancer, molecular target therapy, inflammation, chemical biology
-
E. Tashiro
Showa Pharmaceutical University, JAPAN
Interests: nature chemical biology
-
L. Zhang
University of Pittsburgh, USA
Interests: pharmacology and chemical Biology
Emeritus Editor-in-Chief
-
Late Prof. Kazuo Umezawa
Aichi Medical University, JAPAN
Interests: CPR, resuscitation, critical care medicine, intensive care medicine, hypothermia, emergency management, emergency treatment, sepsis, ventilation, ICU
Login
Register
Submit a Paper
Propose a Special lssue